Dear shareholders and related parties who are supporting us,

How are you?

In 2021, the COVID-19 vaccination was expected to stabilize early when 60 to 65 percent of the nation was vaccinated, but the number of confirmed patients continues to increase even now when the secondary vaccination is more than 85 percent.

Company products, a new product of innovative technology, are also difficult to expand their base by promoting and introducing them because domestic and foreign exhibitions and conferences are not active.

Anyfusion pump demo is still in progress at many university hospitals NICU based on SCI papers and real world reference. Some hospitals, including major hospitals, are positively progressing, and some are taking the next step toward purchasing. I think we need to do both long-term and short-term strategies in case by case.

As a result of manual demo with Anyfusion ACPi V100, most hospitals require HIS-linked Anyfusion ACPi automation. It has been confirmed that the cost-effectiveness is high in terms of the range, amount, and price of the robot comparison between single ACPi pro and semi-automatic ACPi V100, which will be developed and licensed this year. Multi ACPi pro will be developed and licensed next year.

As a government-supported project, we are planning to deliver 120 Anyfusion pumps to 2 major university hospitals, Y hospitals, and A hospitals for 3 years from this year.

U Hospital, a university hospital in Uijeongbu, is planning to proceed from this month after receiving a request for ACPI V100 demo due to an increase in the number of anticancer drugs prepared. This year, NICU Anyfusion pump listing at four to five university hospitals is expected to secure safety and effectiveness, expand hospitals in stages, and expand pump use, allowing integrated ACPI sales from preparation to injection without separate pump purchases.

Overseas businesses are negotiating exclusive supply of tens of billions of won annually with major U.S. company B, and also negotiating entry into the Spanish market.

Italian company A, which consulted with us at MEDICA in 2021, is also negotiating with pump for exclusive ACPI supply.

As such, we would like to prepare for IPO to generate stable profits through restructuring with long-term and short-term strategies.